Equities Analysts Issue Forecasts for SBC FY2024 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Investment analysts at Sidoti Csr dropped their FY2024 earnings per share estimates for SBC Medical Group in a report issued on Wednesday, March 26th. Sidoti Csr analyst A. Shah now anticipates that the company will post earnings of $0.57 per share for the year, down from their prior estimate of $0.58. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.64 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.18 EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.19 EPS and FY2026 earnings at $0.71 EPS.

SBC Medical Group Price Performance

Shares of NASDAQ SBC opened at $3.75 on Thursday. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06. The company’s 50 day moving average is $4.45. SBC Medical Group has a 52 week low of $2.62 and a 52 week high of $12.50.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.